Remove 2017 Remove Leads Remove Pharmaceutical research
article thumbnail

Rapid microbiology testing market growth expected 2022 to 2027

European Pharmaceutical Review

The research includes historic market data from 2017 to 2021, using 2022 as the base year. million in 2017 and continued to grow until 2021. In the report, analysts showed North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country.

Marketing 115
article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

According to GlobalData’s report, Coronavirus Disease 2019 (Covid-19) Analyst Consensus Sales Analysis and Forecast, H1 2022 , Comirnaty is the leading prophylactic Covid-19 vaccine and recorded sales of $41.3bn in 2021.

Sales 108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Decentralized Clinical Trials Are the Wave of the Future

Salesforce

As the global pharmaceutical lead on Salesforce’s Healthcare and Life Sciences Industry Advisory team, I participated in a roundtable discussion with executives from a number of pharmaceutical and contract research organizations (CRO) on how to move forward with clinical trials. . Support innovation.

article thumbnail

Shining a light on Raman for microbiological analysis

European Pharmaceutical Review

7 Raman imaging in pharmaceutical research – an overview The application of Raman spectroscopy in the medical field led to its use in pathogen screening; in turn, this has led to a role in drug development, such as time‑lapse experiments to better understand the bacterial growth‑dependent phenomena and metabolic response to novel antimicrobials.